RecruitingNCT03799653

A Prospective Nurse Cohort Study in Xiamen, China

A Prospective Cohort Study of Common Chronic Diseases on Nurses in Xiamen, China: Nurse Cohort Study Xiamen (NCSX)

Sponsor

The First Affiliated Hospital of Xiamen University

Enrollment

10,000 participants

Start Date

Mar 20, 2019

Study Type

OBSERVATIONAL

Conditions

Hypertension

Summary

The Nurse Cohort Study Xiamen (NCSX) is an open-ended prospective cohort study with very broad research aims. The primary objectives of the NCSX is planned to examine genetic, epigenetic, biological, psychological, social, lifestyle and other environmental factors of nurses in relation to incidence and progression of the common chronic diseases, such as hypertension, ischemic heart disease, stroke, diabetes, chronic kidney disease and some cancers, which are emerging with economic development in Xiamen, China. Specifically, we intend to test whether empirically driven hypothesis and emerging risk factors mainly developed in response to observations in economically developed Western societies apply in a population living in a rapid changing lifestyle in China now.

Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This is a long-term health study following registered nurses working in public hospitals in Xiamen, China. The study will track their health, lifestyle, and working conditions over time to understand factors that influence health outcomes in healthcare workers. **You may be eligible if...** - You are a registered nurse working in a public hospital in Xiamen, China - You are 20 years of age or older - You have been working at the hospital for at least one year - You have signed informed consent and agree to participate - You do not plan to leave Xiamen within the next 5 years **You may NOT be eligible if...** - You are unable to walk or get around independently - You are receiving certain treatments that could not safely be paused for the study - You plan to move out of Xiamen within 5 years Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.